Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on: August 30,2024 0

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on:August 30,2024 0

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on: September 02,2024 0

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on:September 02,2024 0

New genetic tool predicts risk of liver disease in heavy drinkers

byCentenary InstituteCredit: CC0 Public DomainAn international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at r

Updated on: September 03,2024 0

New genetic tool predicts risk of liver disease in heavy drinkers

byCentenary InstituteCredit: CC0 Public DomainAn international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at r

Updated on:September 03,2024 0

The Most Dangerous Black Market You've Never Heard Of

Updated on: September 04,2024 0

The Most Dangerous Black Market You've Never Heard Of

Updated on:September 04,2024 0

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024 0

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024 0

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on: September 11,2024 0

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Updated on:September 11,2024 0

Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment

by Liu Jia,Chinese Academy of SciencesCredit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2024.08.044Liver cancer ranks as the fourth most common cancer and the second

Updated on: September 15,2024 0

Proof-of-concept study demonstrates novel strategy to develop liver-targeting chimeras for disease treatment

by Liu Jia,Chinese Academy of SciencesCredit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2024.08.044Liver cancer ranks as the fourth most common cancer and the second

Updated on:September 15,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on: September 21,2024 0

Metabolic reprogramming and HIF-1α signaling in liver fibrosis and pathological angiogenesis

Updated on:September 21,2024 0